Becky Lynn
Obstetrics & Gynecology · Saint Louis, MONPI 1326003559
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $175,587 of the $230,931 with a category attached, or 76.0%. 31 manufacturers reported payments, led by Therapeuticsmd, Inc. at 38.9% of the total. Among obstetrics & gynecology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $548.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Therapeuticsmd, Inc.$90K
- Astellas Pharma US Inc$71K
- Mayne Pharma Commercial LLC$49K
- Pfizer$9K
- AMAG Pharmaceuticals, Inc.$4K
- Endo USA, Inc.$2K
- plus $6K from 25 others
What the payments were for
- Consulting fees$16,1107%
- Speaking & faculty fees$175,58776%
- Travel & lodging$28,18912%
- Food & beverage$10,8955%
- Education$1510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Therapeuticsmd, Inc. | 150 | $89,845 |
| Astellas Pharma US Inc | 63 | $70,524 |
| Mayne Pharma Commercial LLC | 77 | $48,591 |
| Pfizer | 15 | $9,245 |
| AMAG Pharmaceuticals, Inc. | 9 | $4,253 |
| Endo USA, Inc. | 3 | $2,169 |
| Bayer | 2 | $1,966 |
| Scynexis, Inc. | 4 | $1,085 |
| AbbVie | 22 | $653 |
| Novo Nordisk | 15 | $552 |
| Agile Therapeutics, Inc. | 1 | $538 |
| Lilly USA, LLC | 13 | $336 |
| Millicent US Inc | 22 | $262 |
| Cosette Pharmaceuticals Inc. | 3 | $219 |
| Abbott | 3 | $203 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Vivus LLC | 1 | $65 |
| Kvk-tech, Inc. | 1 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Exact Sciences | 2 | $36 |
| Johnson & Johnson | 2 | $35 |
| Myriad Women's Health, Inc. | 1 | $34 |
| Shield Therapeutics Inc | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $17 |
| Astellas Pharma Global Development | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Lupin Inc. | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$230,931 in reported general payments places this provider in the 95th percentile of 750 obstetrics & gynecology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $11,209 |
| ImvexxyEstradiol | 15 | $4,085 |
| Estradiol (Twice Weekly)Estradiol | 26 | $2,862 |
| ValacyclovirValacyclovir Hcl | 12 | $436 |
| Estradiol | 18 | $320 |
| ProgesteroneProgesterone, Micronized | 11 | $234 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $552 | $11,20912 claims |
| Therapeuticsmd, Inc.Imvexxy | $89,845 | $4,08515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 750 obstetrics & gynecology providers in Missouri.
Other obstetrics & gynecology in Saint Louis
- Kimberly LemoineSaint Louis$30K
- Kaci DurbinSaint Louis$14K
- Wendi CarnsSaint Louis$14K
- Melissa TepeSaint Louis$11K
- Makeba WilliamsSaint Louis$10K
- David WeinsteinSaint Louis$10K
- Jill ScherbelSaint Louis$9K
- Jennifer SmithSaint Louis$8K
- Juliana VerticchioSaint Louis$8K
- Elizabeth WegleitnerSaint Louis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.